Is maternal obsessive-compulsive disorder associated with adverse pregnancy, delivery, and neonatal outcomes?

FHS
June 16, 2023
9:38 am

Researchers assessed the correlation between maternal OCD and pregnancy outcomes.

BMS licenses TCR-T immunotherapy therapy from Immatics – Pharmaceutical Technology

Headquarters of Bristol-Myers Squibb (BMS) Germany in Munich, Germany. BMS has exercised opt-in rights for a new TCR-T therapy from Immatics. Credit: Shutterstock/nitpicker Bristol Myers

May 2, 2023

Rude Awakening on Trying to Keep Donor Hearts Usable With Common Hormone Infusions

Giving unstable brain-dead heart donors intravenous levothyroxine did not lead to more hearts being transplanted, a randomized trial showed. In hemodynamically unstable potential donors, administering

December 1, 2023

Pharma’s reputation with patient groups is sliding again thanks to prices and shortages

The pharmaceutical industry saw its reputation slip last year among patient advocacy groups thanks to growing concern about the rising prices for medicines and a

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.